Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.
D000818:Animals; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy*; D004285:Dogs; D006801:Humans; D006982:Hypertonic Solutions; D008353:Mannitol / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage*
D006982:Hypertonic Solutions; D008353:Mannitol; D008727:Methotrexate